To Evaluate The Efficacy Of TVAGROGJIT In The Management Of Acne Vulgaris

Open Labeled Randomized Active Controlled Comparative Clinical Study To Evaluate Effect Of TVAGROGJIT In The Management Of Yauvanpidika With Special Reference To ACNE VULGARIS

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046573

Enrollment

Registered

2022-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient Between 18 To 30 Years Of Age 2)Patients Will Randomly Selected Irrespective Of Their Sex Religion And Occupation Economical And Educational Status 3) The Diagnosis Will Made On The Basis Of Sign And Symptom Of Yauvanpidika As Per Ayurvedic And Modern Text

Exclusion criteria

Exclusion criteria: 1) Patient Suffering From Any Major Systematic Disorders Like Diabetes Mellitus Hypertension Asthma Tuberculosis HIV OR Other Malignancy 2) Age Below 18 Years And Above 30 Years 3) Complicated Acne With Infection Or The Patients Who Are Taking Medicines For Acne Since Long Time More Than 3 Months

Design outcomes

Primary

Measure	Time frame
It Will Reduce Yauvanpidika And Related Symptoms Like Daha Kandu And VedanaTimepoint: Patient Will Be Evaluated On Baseline 15th Day 30th Day 45th Day And On 60th Day	—

Secondary

Measure	Time frame
It Will Help To Increase Skin ToneTimepoint: Patient Will Be Evaluated On Baseline 15th DAy 30th day 45th Day And On 60th Day	—

Countries

India

Contacts

Public ContactDr Rajkumar Rathod

Parul Insitute Of Ayurveda

shailesh.deshpande260036@paruluniversity.ac.in9763104451

Outcome results